Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
0.732
-0.042 (-5.41%)
Dec 23, 2024, 3:05 PM EST - Market open
Ocugen Employees
Ocugen had 65 employees as of December 31, 2023. The number of employees decreased by 19 or -22.62% compared to the previous year.
Employees
65
Change (1Y)
-19
Growth (1Y)
-22.62%
Revenue / Employee
$72,308
Profits / Employee
-$786,831
Market Cap
213.36M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Aurora Cannabis | 1,073 |
| BGM Group | 298 |
| Biodesix | 217 |
| LifeMD | 211 |
| Precigen | 202 |
| biote | 194 |
| Electromed | 174 |
| Nautilus Biotechnology | 167 |
OCGN News
- 4 days ago - Data and Safety Monitoring Board Reviews Interim Safety Data of Phase 2 Subjects of OCU410 ArMaDa Clinical Trial for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration - GlobeNewsWire
- 12 days ago - Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit - GlobeNewsWire
- 26 days ago - Ocugen CEO to Present at NobleCon20 – Noble Capital Markets' 20th Annual Emerging Growth Equity Conference - GlobeNewsWire
- 4 weeks ago - Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate OCU410ST for Treatment of ABCA4-Associated Retinopathies including Stargardt Disease - GlobeNewsWire
- 4 weeks ago - Ocugen Announces Compelling Preliminary Data for OCU410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration - GlobeNewsWire
- 6 weeks ago - Ocugen, Inc. (OCGN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Ocugen Provides Business Update with Third Quarter 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Ocugen Secures $30 Million in Debt Funding - GlobeNewsWire